BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 38177930)

  • 1. Hotspot propensity across mutational processes.
    Arnedo-Pac C; Muiños F; Gonzalez-Perez A; Lopez-Bigas N
    Mol Syst Biol; 2024 Jan; 20(1):6-27. PubMed ID: 38177930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequence dependencies and mutation rates of localized mutational processes in cancer.
    Poulsgaard GA; Sørensen SG; Juul RI; Nielsen MM; Pedersen JS
    Genome Med; 2023 Aug; 15(1):63. PubMed ID: 37592287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An analysis of mutational signatures of synonymous mutations across 15 cancer types.
    Bin Y; Wang X; Zhao L; Wen P; Xia J
    BMC Med Genet; 2019 Dec; 20(Suppl 2):190. PubMed ID: 31815613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hotspot mutations delineating diverse mutational signatures and biological utilities across cancer types.
    Chen T; Wang Z; Zhou W; Chong Z; Meric-Bernstam F; Mills GB; Chen K
    BMC Genomics; 2016 Jun; 17 Suppl 2(Suppl 2):394. PubMed ID: 27356755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of mutation signature effectuating processes with mutation hotspots in driver genes and non-coding regions.
    Wong JKL; Aichmüller C; Schulze M; Hlevnjak M; Elgaafary S; Lichter P; Zapatka M
    Nat Commun; 2022 Jan; 13(1):178. PubMed ID: 35013316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two main mutational processes operate in the absence of DNA mismatch repair.
    Németh E; Lovrics A; Gervai JZ; Seki M; Rospo G; Bardelli A; Szüts D
    DNA Repair (Amst); 2020 May; 89():102827. PubMed ID: 32126497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional and genetic determinants of mutation rate variability in regulatory elements of cancer genomes.
    Lee CA; Abd-Rabbo D; Reimand J
    Genome Biol; 2021 May; 22(1):133. PubMed ID: 33941236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. decompTumor2Sig: identification of mutational signatures active in individual tumors.
    Krüger S; Piro RM
    BMC Bioinformatics; 2019 Apr; 20(Suppl 4):152. PubMed ID: 30999866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns and processes of somatic mutations in nine major cancers.
    Jia P; Pao W; Zhao Z
    BMC Med Genomics; 2014 Feb; 7():11. PubMed ID: 24552141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A full-proteome, interaction-specific characterization of mutational hotspots across human cancers.
    Chen S; Liu Y; Zhang Y; Wierbowski SD; Lipkin SM; Wei X; Yu H
    Genome Res; 2022 Jan; 32(1):135-149. PubMed ID: 34963661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of cancer mutational signatures on transcription factor motifs in the human genome.
    Yiu Chan CW; Gu Z; Bieg M; Eils R; Herrmann C
    BMC Med Genomics; 2019 May; 12(1):64. PubMed ID: 31109337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Base damage, local sequence context and TP53 mutation hotspots: a molecular dynamics study of benzo[a]pyrene induced DNA distortion and mutability.
    Menzies GE; Reed SH; Brancale A; Lewis PD
    Nucleic Acids Res; 2015 Oct; 43(19):9133-46. PubMed ID: 26400171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Theoretical analysis of mutation hotspots and their DNA sequence context specificity.
    Rogozin IB; Pavlov YI
    Mutat Res; 2003 Sep; 544(1):65-85. PubMed ID: 12888108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A near-deterministic mutational hotspot in Pseudomonas fluorescens is constructed by multiple interacting genomic features.
    Shepherd MJ; Horton JS; Taylor TB
    Mol Biol Evol; 2022 Jun; 39(6):. PubMed ID: 35707979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clock-like mutational processes in human somatic cells.
    Alexandrov LB; Jones PH; Wedge DC; Sale JE; Campbell PJ; Nik-Zainal S; Stratton MR
    Nat Genet; 2015 Dec; 47(12):1402-7. PubMed ID: 26551669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A site specific model and analysis of the neutral somatic mutation rate in whole-genome cancer data.
    Bertl J; Guo Q; Juul M; Besenbacher S; Nielsen MM; Hornshøj H; Pedersen JS; Hobolth A
    BMC Bioinformatics; 2018 Apr; 19(1):147. PubMed ID: 29673314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatic mutational profiles and germline polygenic risk scores in human cancer.
    Liu Y; Gusev A; Heng YJ; Alexandrov LB; Kraft P
    Genome Med; 2022 Feb; 14(1):14. PubMed ID: 35144655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parental influence on human germline de novo mutations in 1,548 trios from Iceland.
    Jónsson H; Sulem P; Kehr B; Kristmundsdottir S; Zink F; Hjartarson E; Hardarson MT; Hjorleifsson KE; Eggertsson HP; Gudjonsson SA; Ward LD; Arnadottir GA; Helgason EA; Helgason H; Gylfason A; Jonasdottir A; Jonasdottir A; Rafnar T; Frigge M; Stacey SN; Th Magnusson O; Thorsteinsdottir U; Masson G; Kong A; Halldorsson BV; Helgason A; Gudbjartsson DF; Stefansson K
    Nature; 2017 Sep; 549(7673):519-522. PubMed ID: 28959963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel hotspot detector software reveals a non-CpG hotspot of germline mutation in the factor IX gene (F9) in Latin Americans.
    Drost JB; Scaringe WA; Jaloma-Cruz AR; Li X; Ossa DF; Kasper CK; Sommer SS
    Hum Mutat; 2000 Sep; 16(3):203-10. PubMed ID: 10980527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regularized sequence-context mutational trees capture variation in mutation rates across the human genome.
    Adams CJ; Conery M; Auerbach BJ; Jensen ST; Mathieson I; Voight BF
    PLoS Genet; 2023 Jul; 19(7):e1010807. PubMed ID: 37418489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.